A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response

James M. Foran, Rajnish K. Gupta, David Cunningham, Razvan A. Popescu, Anthony H. Goldstonk, John W. Sweetenham, Ruth Pettengell, Peter W.M. Johnson, Eric Bessell, Barry Hancock, Karin Summers, Julia Hughes, Ama Z.S. Rohatiner, T. Andrew Lister

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Fingerprint Dive into the research topics of 'A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response'. Together they form a unique fingerprint.

Medicine & Life Sciences